There was no statistically significant difference between the patients with IBS and the healthy controls in terms of serum VEGF and endostatin levels (P = 0.709 and P = 0.562, respectively) (Figures 3and4). This evidence concerns the gene COL18A1 and irritable bowel syndrome.